[HTML][HTML] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - nature.com
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
[引用][C] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - cir.nii.ac.jp
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
| CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchie, L Dagna… - NATURE REVIEWS …, 2021 - iris.unisr.it
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchie, L Dagna… - Nature Reviews …, 2021 - epub.ub.uni-muenchen.de
Here, the authors propose that SARS-CoV-2 induces a prothrombotic state, with
dysregulated immunothrombosis in lung microvessels and endothelial injury, which drive …
dysregulated immunothrombosis in lung microvessels and endothelial injury, which drive …
[HTML][HTML] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - Nature Reviews …, 2021 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - Nature reviews …, 2021 - pubmed.ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19.
A Bonaventura, A Vecchié, L Dagna… - Nature reviews …, 2021 - europepmc.org
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchie, L Dagna… - NATURE REVIEWS …, 2021 - irinsubria.uninsubria.it
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié… - Nature …, 2021 - researchinformation.amsterdamumc …
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
[PDF][PDF] Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
A Bonaventura, A Vecchié, L Dagna… - NaTuRe RevIeWS …, 2021 - iris.unisr.it
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe …